These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26290195)

  • 1. Formulation Approaches to Overcome Biopharmaceutical Limitations of Inhaled Peptides/Proteins.
    Onoue S; Suzuki H; Seto Y
    Curr Pharm Des; 2015; 21(27):3867-74. PubMed ID: 26290195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.
    Thwala LN; Préat V; Csaba NS
    Expert Opin Drug Deliv; 2017 Jan; 14(1):23-36. PubMed ID: 27351299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
    Brayden DJ; Hill TA; Fairlie DP; Maher S; Mrsny RJ
    Adv Drug Deliv Rev; 2020; 157():2-36. PubMed ID: 32479930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel delivery technologies for protein and peptide therapeutics.
    Kumar TR; Soppimath K; Nachaegari SK
    Curr Pharm Biotechnol; 2006 Aug; 7(4):261-76. PubMed ID: 16918403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery.
    Hu X; Yang FF; Liao YH
    Curr Pharm Des; 2016; 22(17):2532-48. PubMed ID: 26818873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal delivery of proteins and peptides.
    Swaminathan J; Ehrhardt C
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1489-503. PubMed ID: 23092138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocarriers for pulmonary administration of peptides and therapeutic proteins.
    Andrade F; Videira M; Ferreira D; Sarmento B
    Nanomedicine (Lond); 2011 Jan; 6(1):123-41. PubMed ID: 21182424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review on parenteral delivery of peptides and proteins.
    Jain D; Mahammad SS; Singh PP; Kodipyaka R
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1403-1420. PubMed ID: 31215293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.
    Bak A; Leung D; Barrett SE; Forster S; Minnihan EC; Leithead AW; Cunningham J; Toussaint N; Crocker LS
    AAPS J; 2015 Jan; 17(1):144-55. PubMed ID: 25398427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site.
    Kinnunen HM; Mrsny RJ
    J Control Release; 2014 May; 182():22-32. PubMed ID: 24631859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
    Philippart M; Schmidt J; Bittner B
    Drug Res (Stuttg); 2016 Mar; 66(3):113-20. PubMed ID: 26536331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart polymers for controlled delivery of proteins and peptides: a review of patents.
    Fogueri LR; Singh S
    Recent Pat Drug Deliv Formul; 2009 Jan; 3(1):40-8. PubMed ID: 19149728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled proteins: challenges and perspectives.
    Depreter F; Pilcer G; Amighi K
    Int J Pharm; 2013 Apr; 447(1-2):251-80. PubMed ID: 23499756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile Salt Stabilized Vesicles (Bilosomes): A Novel Nano-Pharmaceutical Design for Oral Delivery of Proteins and Peptides.
    Ahmad J; Singhal M; Amin S; Rizwanullah M; Akhter S; Kamal MA; Haider N; Midoux P; Pichon C
    Curr Pharm Des; 2017; 23(11):1575-1588. PubMed ID: 28120725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in oral peptide delivery: lessons learnt from the clinic and future prospects.
    Richard J
    Ther Deliv; 2017 Jul; 8(8):663-684. PubMed ID: 28730934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Design and Biopharmaceutical Evaluations of Peptide-loaded Inhalable Formulation to Control Pharmacokinetic Behavior].
    Sato H
    Yakugaku Zasshi; 2020; 140(11):1305-1312. PubMed ID: 33132265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery Technologies for Orally Inhaled Products: an Update.
    Moon C; Smyth HDC; Watts AB; Williams RO
    AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-invasive protein and peptide drug delivery approaches.
    Wallis L; Kleynhans E; Toit TD; Gouws C; Steyn D; Steenekamp J; Viljoen J; Hamman J
    Protein Pept Lett; 2014; 21(11):1087-101. PubMed ID: 25106909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.